Celltrion Takes Big Step On Xolair Biosimilar Journey

Phase I Trial For Omalizumab Candidate Began Last Year

 
• By Dean Rudge
  
Growth
Celltrion has secured safety data from the interim results of Phase I clinical trials • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Products

More from Generics Bulletin